Correction for Barnes, BMJ 335 (7618) 513.

BMJ  2007;335 (22 September), doi:10.1136/bmj.39342.450382.AD

Corrections

Change Page: Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control

An editorial oversight led this Practice article by Peter J Barnes (BMJ 2007;335:513, 8 Sep, doi: 10.1136/bmj.39273.537778.AD) to claim that the author had no competing interests. In fact, in his original manuscript he had declared: "PB receives research funding from AstraZeneca, GlaxoSmithKline, Novartis, Pfizer, and Boehringer Ingelheim, all of whom are involved in the development of asthma therapies."


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Student BMJ

Sepsis

The latest guidlines will affect how we practice medicine

www.student.bmj.com

Listen to the latest BMJ Interview